Issue 5, 2011

Esterprodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies

Abstract

Novel esterprodrugs of ciprofloxacin were synthesized, and tested for their antimalarial and antitoxoplasma activity. These new compounds proved to be extremely efficient against these parasites. Molecular modeling and computational calculations were used to understand the mechanisms of action of these drugs.

Graphical abstract: Ester prodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies

Supplementary files

Article information

Article type
Concise Article
Submitted
20 Jan 2011
Accepted
03 Mar 2011
First published
17 Mar 2011

Med. Chem. Commun., 2011,2, 430-435

Ester prodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies

F. Dubar, R. Wintjens, É. S. Martins-Duarte, R. C. Vommaro, W. de Souza, D. Dive, C. Pierrot, B. Pradines, A. Wohlkonig, J. Khalife and C. Biot, Med. Chem. Commun., 2011, 2, 430 DOI: 10.1039/C1MD00022E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements